Myeloma UK Launches Reolysin Combo Trial for Relapsing Myeloma Patients
The cancer charity Myeloma UK has launched a Phase 1…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreThe cancer charity Myeloma UK has launched a Phase 1…
Don Wright, who recently finished his 100th marathon while…
Multiple myeloma patients undergoing autologous stem cell transplants (ASCT)…
GlycoMimetics will present preclinical research at the…
Celyad is ready to enroll patients in its Phase 1…
Patients with relapsed or refractory multiple myeloma who receive a…